🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06215274
Recruiting Observational

Cognitive Leisure and Preclinical Alzheimer's Disease: Exploring Neural Mechanisms

NCT06215274 · tracked via the Priya Life Science China tracker
Sponsor
Yuanjiao Yan
Phase
Observational
Started
2024-04-27
Last updated
2024-05-17

Condition(s) studied

Cognitive Dysfunction

Investigational drug(s) / intervention(s)

Relationship of the cognitive leisure activity levels, cognitive function, and MRI characteristics.

Relationship of the cognitive leisure activity levels, cognitive function, and MRI characteristics.: The cognitive leisure activity levels, cognitive function, and MRI characteristics in people in the preclinical stage of Alzheimer's Disease (AD).

Study summary

The goal of this clinical trial is aims to:

1. Translate and culturally adapt the Cognitive Leisure Activity Scale (CLAS) into Chinese and Conduct reliability and validity tests for the Chinese version of CLAS.
2. Investigate the correlation between cognitive leisure activity levels and cognitive function in the preclinical stage of Alzheimer's Disease (AD).
3. Clarify the regulatory mechanisms of cognitive leisure activity levels on the neural circuits of patients in the preclinical stage of AD.

Eligibility

Sex
ALL
Min age
60 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Clinical diagnosis of Mild Cognitive Impairment (MCI) and Subjective Cognitive Decline (SCD) * Age ≥ 60 years * Capable of normal communication in Mandarin,possesses a certain level of comprehension and judgment. Exclusion Criteria: * Individuals with severe hearing or language impairments, or with severe physical illnesses that are unable to cooperate with the survey * Individuals with pacemakers, metallic implants, cochlear implants, claustrophobia, and other contraindications for MRI examination.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fujian Provincial Hospital Fuzhou Fujian Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06215274 on ClinicalTrials.gov ↗ ← All trials in China